[go: up one dir, main page]

ES2134213T3 - Nuevos glicoesfingolipidos y empleo de los mismos. - Google Patents

Nuevos glicoesfingolipidos y empleo de los mismos.

Info

Publication number
ES2134213T3
ES2134213T3 ES92909489T ES92909489T ES2134213T3 ES 2134213 T3 ES2134213 T3 ES 2134213T3 ES 92909489 T ES92909489 T ES 92909489T ES 92909489 T ES92909489 T ES 92909489T ES 2134213 T3 ES2134213 T3 ES 2134213T3
Authority
ES
Spain
Prior art keywords
new
glycosphingolipids
employment
integer
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909489T
Other languages
English (en)
Inventor
Tatsuo Higa
Koji Akimoto
Yasuhiko Koezuka
Teruyuki Sakai
Masahiro Morita
Takenori Natori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Application granted granted Critical
Publication of ES2134213T3 publication Critical patent/ES2134213T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTA UN NUEVO SFINGOGLICOLIPIDO REPRESENTADO POR LA FORMULA GENERAL (A), EN DONDE E REPRESENTA -CH(R2)-(CH2)X-H O (CH2)7CH=CH(CH2)7-CH3; R1 REPRESENTA -CH(R2)-(CH2)Y-R3 O -CH=CH(CH2)Y-CH3; R2 REPRESENTA H O OH; R3 REPRESENTA METILO, ISOPROPILO O SEC-BUTILO; X REPRESENTA UN ENTERO ENTRE 0 Y 26; E Y REPRESENTA UN ENTERO ENTRE 5 Y 17. TAMBIEN SE PRESENTA UN AGENTE ANTINEOPLASTICO Y UN INMUNOPOTENCIADOR QUE CONTIENEN AL MENOS UNO DE LOS COMPUESTOS ANTES MENCIONADOS COMO INGREDIENTE ACTIVO. ASIMISMO SE PRESENTA UN PROCESO PARA PREPARAR UN SFINGOGLICOLIPIDO TOMANDO EL SFINGOGLICOLIPIDO ESPECIFICO DE UNA ESPONJA "AGELAS MAURITIANUS".
ES92909489T 1991-08-29 1992-04-28 Nuevos glicoesfingolipidos y empleo de los mismos. Expired - Lifetime ES2134213T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3244384A JPH0559081A (ja) 1991-08-29 1991-08-29 新規スフインゴ糖脂質、その製造法および使用

Publications (1)

Publication Number Publication Date
ES2134213T3 true ES2134213T3 (es) 1999-10-01

Family

ID=17117885

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909489T Expired - Lifetime ES2134213T3 (es) 1991-08-29 1992-04-28 Nuevos glicoesfingolipidos y empleo de los mismos.

Country Status (18)

Country Link
EP (1) EP0609437B1 (es)
JP (2) JPH0559081A (es)
KR (1) KR100220793B1 (es)
AT (1) ATE181922T1 (es)
AU (1) AU665536B2 (es)
CA (1) CA2116442C (es)
DE (1) DE69229557T2 (es)
DK (1) DK0609437T3 (es)
ES (1) ES2134213T3 (es)
FI (1) FI105189B (es)
GR (1) GR3030723T3 (es)
HU (1) HU223839B1 (es)
NO (1) NO180338C (es)
PT (1) PT100736B (es)
SG (1) SG44031A1 (es)
TW (1) TW197446B (es)
WO (1) WO1993005055A1 (es)
ZA (1) ZA923239B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (es) * 1992-07-16 1995-11-01 Kirin Brewery
EP0666268B1 (en) * 1992-10-22 2000-04-19 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
CA2160566C (en) * 1993-04-15 2004-07-13 Tatsuo Higa Novel sphingoglycolipids and uses thereof
TW555562B (en) 1996-12-27 2003-10-01 Kirin Brewery Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
NZ519957A (en) * 2000-01-14 2003-08-29 Meiji Dairies Corp Antigen-specific IgE antibody production inhibitors
JP2002030093A (ja) * 2000-03-13 2002-01-29 Nof Corp グリコシルセラミドの精製方法
KR100880063B1 (ko) 2001-08-16 2009-01-22 아스비오파마 가부시키가이샤 신규한 당지질 및 이것을 유효성분으로 하는 자기면역질환 치료약
JPWO2004026318A1 (ja) * 2002-09-20 2006-01-12 麒麟麦酒株式会社 α−グリコシルセラミドを有効成分とするＣ型肝炎ウイルス抑制剤
JP4585172B2 (ja) * 2003-01-31 2010-11-24 森永乳業株式会社 骨形成促進剤
CN100537585C (zh) * 2003-02-14 2009-09-09 阿斯比奥制药株式会社 糖脂衍生物及其制造方法,以及其合成中间体及其制造方法
JP4753089B2 (ja) * 2004-12-20 2011-08-17 株式会社岡安商店 体内脂肪の分解促進作用を有する組成物及びそれを含有する食品又は食品配合剤
JP2007070311A (ja) * 2005-09-09 2007-03-22 Gunma Univ α−ガラクトシルセラミドからなる感染症予防剤及び感染症治療剤
EP1776963A1 (en) 2005-10-19 2007-04-25 Gbf-Gesellschaft Für Biotechnologische Forschung Mbh Hexosylceramides as adjuvants and their uses in pharmaceutical compositions
WO2008047174A1 (en) * 2006-10-18 2008-04-24 Centre National De La Recherche Scientifique Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
EP2117583B1 (en) 2007-02-21 2013-05-22 Vib Vzw Combination therapy using TNF and alpha-galactosyl ceramide
JP4995172B2 (ja) * 2008-10-10 2012-08-08 壽製薬株式会社 糖脂質誘導体、その製造方法並びにそれを有効成分とする医薬
CN102395375B (zh) 2009-02-16 2015-01-14 塞伦尼斯医疗控股有限公司 载脂蛋白a-i模拟物
JP5095683B2 (ja) * 2009-07-06 2012-12-12 壽製薬株式会社 新規糖脂質誘導体及びこれを有効成分とする製剤
JP5025692B2 (ja) * 2009-07-06 2012-09-12 壽製薬株式会社 糖脂質誘導体の製造方法
JP2010254718A (ja) * 2010-08-13 2010-11-11 Morinaga Milk Ind Co Ltd 骨形成促進剤
HUE034637T2 (en) 2010-10-18 2018-02-28 Cerenis Therapeutics Holding Sa Compounds, compositions and methods for mobilizing cholesterol
EP2647384B1 (en) 2010-12-02 2018-05-23 Riken IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH alpha CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM V alpha-J alpha , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
JP6233890B2 (ja) * 2012-08-03 2017-11-22 国立研究開発法人理化学研究所 水酸化ｋｒｎ７０００類縁体及びその用途
WO2014053482A1 (en) 2012-10-03 2014-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
WO2014079946A1 (en) 2012-11-21 2014-05-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for determining the risk of acute graft versus host disease
WO2017207040A1 (en) 2016-06-01 2017-12-07 Vib Vzw ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR
KR102328367B1 (ko) * 2019-11-05 2021-11-18 한국해양과학기술원 아젤록심 d를 유효성분으로 함유하는 방사선 민감성 증진용 조성물
JPWO2022118913A1 (es) 2020-12-04 2022-06-09

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6157594A (ja) * 1984-08-30 1986-03-24 Suntory Ltd ガラクトスフインゴ脂質及びその製造法
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
JP3068910B2 (ja) * 1990-11-08 2000-07-24 麒麟麦酒株式会社 新規スフィンゴ糖脂質、その製造法および使用

Also Published As

Publication number Publication date
WO1993005055A1 (fr) 1993-03-18
EP0609437A4 (en) 1994-08-24
HK1009967A1 (en) 1999-09-17
AU1666492A (en) 1993-04-05
PT100736A (pt) 1993-09-30
SG44031A1 (en) 1997-11-14
DE69229557T2 (de) 1999-11-25
JP2774194B2 (ja) 1998-07-09
HU9400596D0 (en) 1994-05-30
ZA923239B (en) 1993-05-05
PT100736B (pt) 1999-04-30
GR3030723T3 (en) 1999-11-30
HU223839B1 (hu) 2005-02-28
NO940598L (es) 1994-04-27
FI105189B (fi) 2000-06-30
EP0609437B1 (en) 1999-07-07
EP0609437A1 (en) 1994-08-10
NO180338C (no) 1997-04-02
NO180338B (no) 1996-12-23
CA2116442C (en) 2000-09-05
DK0609437T3 (da) 2000-01-31
DE69229557D1 (de) 1999-08-12
NO940598D0 (no) 1994-02-22
TW197446B (es) 1993-01-01
AU665536B2 (en) 1996-01-11
CA2116442A1 (en) 1993-03-18
KR100220793B1 (ko) 1999-10-01
ATE181922T1 (de) 1999-07-15
FI940851A7 (fi) 1994-02-23
JPH0559081A (ja) 1993-03-09
HUT70435A (en) 1995-10-30
FI940851A0 (fi) 1994-02-23

Similar Documents

Publication Publication Date Title
ES2134213T3 (es) Nuevos glicoesfingolipidos y empleo de los mismos.
MX9203239A (es) Derivados de 1-(dihidroxifenil)-2-amino-etanol y composiciones farmaceuticas que los contienen.
DK0835258T3 (da) Hidtil ukendte camptothecin-analoger, fremgangsmåder til fremstilling heraf, anvendelse heraf som lægemidler og farmaceutiske præparater indeholdende disse
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
SE8303013L (sv) B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening
CA2013166A1 (en) Suppression of parathyroid hormone synthesis and secretion
ES2066060T3 (es) Solucion humectada para impresion litografica.
SE7909916L (sv) Beta,gamma-dihydropolyprenylalkoholer och farmaceutiska kompositioner innehallande desamma
BR0109979A (pt) Composição herbicida aquosa
IL65322A (en) Non-irritating pour-on compositions containing tetramisole or levamisole for combating helmintic infestations in animals
IL63597A (en) Cyclohexane-1,3-dione derivatives,their preparation and their use as herbicides
JPS5234922A (en) Novel antimicrobial agent for non-medical use
ES2101910T3 (es) Composicion para acelerar la curacion de heridas.
DE3160851D1 (en) Lidocaine derivative and therapeutic compositions which contain it as their active principle
EP0598117A4 (en) BENZOPYRAN DERIVATIVE AND ANTI-ALLERGIC AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT.
MX9302832A (es) Nuevo medicamento para el tratamiento de la arritmia.
ES2063055T3 (es) Esteres de tipo etretinico o emparentado de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
FI890482A0 (fi) B-laktam-antibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel och i laekemedel.
DK0485894T3 (da) Fremgangsmåde til fremstilling af semisyntetiske diastereomerrene N-glycidyl-anthracycliner
PE39099A1 (es) Pastilla para limpieza personal de glicerina con poliglucosido alquilo
JPS572205A (en) Industrial germicide
JPS54135235A (en) Improved enamel remover composition
FI824061L (fi) Foerfarande foer framstaellning av nya 3'''-dehydro-kardenolid-tridigitoxosidoximer och anvaendningdem som laekemedel
JPS53137964A (en) Thiazole type compounds and herbicides containing the same as active constituents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 609437

Country of ref document: ES